Acute optic neuritis: Combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis

Journal of the Neurological Sciences

Volumn 155, Issue 1, 1998, Pages 44-49

  Tumani, Hayrettin ^a   Tourtellotte, Wallace W ^b   Peter, James B ^c   Felgenhauer, Klaus ^a   The Optic Neuritis Study Group, ^d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Specialty Laboratories   (United States)

^d NONE

Author keywords

Blood CSF barrier; Cerebrospinal fluid; Intrathecal IgG; MRI; Multiple sclerosis; Optic neuritis treatment prognosis; Viral specific antibodies

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID ANALYSIS; CHICKENPOX; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; ISOELECTRIC FOCUSING; MEASLES; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RUBELLA; STATISTICAL ANALYSIS; VIRUS DIAGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; HERPESVIRUS 3, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MEASLES VIRUS; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RUBELLA VIRUS;

EID: 0002348524     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00272-4     Document Type: Article

References (35)

1. Andersson M., Alvarez-Cermeno J., Bernardi G.et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry. 57:1994;897-902.
2. Anmarkrud N., Slettnes O.N. Uncomplicated retrobulbar neuritis and the development of multiple sclerosis. Acta Ophthalmol. (Copenh.). 67:1989;306-309.
3. Beck R.W. The optic neuritis treatment trial: 3 year follow-up results. Arch. Ophthalmol. 113:1995;136-137.
4. Beck R.W., Cleary P.A., Anderson M.M. Jr.et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. New Engl. J. Med. 326:1992;581-588.
5. Beck R.W., Arrington J., Murtaugh F.R. Brain magnetic resonance imaging in acute optic neuritis. Arch. Neurol. 50:1993;841-846.
6. Ebers G.C. Optic neuritis and multiple sclerosis. Arch. Neurol. 42:1985;702-704.
7. Felgenhauer K., Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin. Invest. 70:1992;28-37.
8. Felgenhauer K., Schliep G., Rapic N. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J. Neurol. Sci. 30:1976;113-128.
9. Felgenhauer K., Schädlich H.-J., Nekic M., Ackermann R. Cerebrospinal fluid antibodies: a diagnostic indicator for multiple sclerosis? J. Neurol. Sci. 71:1985;291-299.
10. Filippini G., Comi G.C., Cosi V.et al. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J. Neurol. 241:1994;132-137.
11. Frederiksen J.L., Larsson H.B.W., Olesen J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol. Scand. 86:1992;317-322.
12. Godec M.S., Asher D.M., Murray R.S.et al. Absence of measles, mumps, and rubella viral genomic sequences from multiple sclerosis brain tissue by polymerase chain reaction. Ann. Neurol. 32:1992;401-404.
13. Jacobs L., Kinkel P.R., Kinkel W.R. Silent brain lesions in patients with isolated idiopathic optic neuritis. Arch. Neurol. 43:1986;452-455.
14. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 37:1977;397-401.
15. Nicoll J.A.R., Kinrade E., Love S. PCR-mediated search for herpes simplex virus DNA in sections of brain from patients with multiple sclerosis and other neurological disorders. J. Neurol. Sci. 113:1992;144-151.
16. Oakley B.R., Kirsch D.R., Morris N.R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal. Biochem. 105:1980;361-363.
17. Paolino E., Fainardi E., Ruppi P.et al. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 60:1996;572-575.
18. Paty D.W., Oger J.J.F., Kastrukoff L.F.et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 38:1988;180-185.
19. Peter J.B., Bowman R.L. Intra-blood-brain barrier synthesis of IgG: comparison of IgG synthesis formulas in a computer model and in 1629 consecutive specimens. Neurology. 42:1992;510-515.
20. Peter J.B., McKeown K.L., Agopian M.S. Assessment of different methods to detect increased autochthonous production of immunoglobulin G and oligoclonal immunoglobulins in multiple sclerosis. Am. J. Clin. Pathol. 97:1992;858-860.
21. Poser C.M., Paty D.W., Scheinberg L.et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
22. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta. 163:1987;319-328.
23. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 37:1991;1153-1160.
24. Rizzo J.F., Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. 38:1988;185-190.
25. Rolak L.A., Beck R.W., Paty D.W., Tourtellotte W.W., Whitaker J.N., Rudick R.A. For the Optic Neuritis Study Group, Cerebrospinal fluid in acute optic neuritis: Experience of the optic neuritis treatment trial. Neurology. 46:1996;368-372.
26. Rudick R.A., Jacobs L., Kinkel P.R., Kinkel W.R. Isolated idiopathic optic neuritis. Arch. Neurol. 43:1986;456-458.
27. Sandberg-Wollheim M. Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol. Scand. 52:1975;167-178.
28. Sandberg-Wollheim M., Vandvik B., Nadj C., Norrby E. The intrathecal immune response in the early stage of multiple sclerosis. J. Neurol. Sci. 81:1987;45-53.
29. Schipper H.I., Neumayer H., Poser S. Prognostischer Wert der lokalen IgGProduktion bei monosymptomatischer Optikusneuritis. Akt. Neurol. 11:1984;73-76.
30. Sindic C.J.M., Monteyne Ph., Laterre E.C. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J. Neuroimmunol. 54:1994;75-80.
31. Staugaitis S.M., Shapshak P., Tourtellotte W.W., Lee M.M., Reiber H. Isoelectric focusing of unconcentrated cerebrospinal fluid: applications to ultrasensitive analysis of oligoclonal immunoglobulin G. Electrophoresis. 6:1985;287-291.
32. Stendahl-Brodin L., Link H. Optic neuritis oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol. Scand. 67:1983;301-304.
33. Syndulko K., Tourtellotte W.W., Conrad A.J.et al. Trans-blood-brainbarrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients. J. Neuroimmunol. 46:1993;185-192.
34. Tourtellotte W.W., Staugaitis S.M., Walsh M.J.et al. The basis of intra-blood-brain-barrier IgG synthesis. Ann. Neurol. 17:1985;21-27.
35. Zweig, M.H., Robertson, E.A., 1987. Clinical validation in immunoassays: a well-designed approach to a clinical study. In: Chan, D.W. (Ed.), Immunoassay, a Practical Guide. Academic Press, London, pp. 97-127.